Jan 4, 2026 · Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to treat osteoporosis in postmenopausal …

Jan 4, 2026 · Denosumab (Prolia, Bildyos, Boncresa, Bosaya, Conexxence, Enoby, Jubbonti, Ospomyv, Osvyrti, and Stoboclo brands/biosimilars) is used to treat osteoporosis that occurs …

Nov 13, 2025 · Easy-to-read patient tips for denosumab covering how it works, benefits, risks, and best practices.

Easy-to-read patient leaflet for Denosumab Injection (Prolia). Includes indications, proper use, special instructions, precautions, and possible side effects.

May 29, 2024 · Jubbonti (denosumab-bbdz) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to treat osteoporosis in …

Sep 16, 2025 · Detailed dosage guidelines and administration information for Prolia (denosumab). Includes dose adjustments, warnings and precautions.

Oct 30, 2025 · Detailed dosage guidelines and administration information for Jubbonti (denosumab). Includes dose adjustments, warnings and precautions.

Dec 18, 2025 · Learn about the side effects of denosumab, from common to rare, for consumers and healthcare professionals.

Jan 4, 2026 · Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is also used to treat giant cell tumor of bone and lower blood calcium levels in …

Nov 20, 2025 · Jubbonti (denosumab-bbdz) injection is a sterile, preservative-free, clear to slightly opalescent and colorless to slightly yellowish to slightly brownish solution for subcutaneous use.